BCAL Diagnostics (ASX:BDX) FCF Margin % : 0.00% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BCAL Diagnostics's Free Cash Flow for the six months ended in Dec. 2024 was A$-3.41 Mil. BCAL Diagnostics's Revenue for the six months ended in Dec. 2024 was A$0.00 Mil. Therefore, BCAL Diagnostics's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

As of today, BCAL Diagnostics's current FCF Yield % is -23.22%.

The historical rank and industry rank for BCAL Diagnostics's FCF Margin % or its related term are showing as below:

ASX:BDX's FCF Margin % is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: -2.33
* Ranked among companies with meaningful FCF Margin % only.

BCAL Diagnostics FCF Margin % Historical Data

The historical data trend for BCAL Diagnostics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics FCF Margin % Chart

BCAL Diagnostics Annual Data

Trend

Jun22

Jun23

Jun24

FCF Margin %

BCAL Diagnostics Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
FCF Margin %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of BCAL Diagnostics's FCF Margin %

For the Diagnostics & Research subindustry, BCAL Diagnostics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BCAL Diagnostics's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BCAL Diagnostics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BCAL Diagnostics's FCF Margin % falls into.

Save Embed

;

Save Embed

;

BCAL Diagnostics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BCAL Diagnostics's FCF Margin for the fiscal year that ended in Jun. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2024 )	/	Revenue (A: Jun. 2024 )
	=	-5.674	/	0
	=	%

BCAL Diagnostics's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-3.414	/	0
	=	%

BCAL Diagnostics FCF Margin % Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

BCAL Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230

Website

https://www.bcaldiagnostics.com

BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.